Hologic Q3 2024 Adj EPS $1.06 Beats $1.02 Estimate, Sales $1.011B Beat $1.000B Estimate
Portfolio Pulse from Benzinga Newsdesk
Hologic (NASDAQ:HOLX) reported Q3 2024 adjusted EPS of $1.06, beating the analyst estimate of $1.02. The company also reported sales of $1.011 billion, surpassing the $1.000 billion estimate. This represents a 2.74% increase over the same period last year.
July 29, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hologic reported Q3 2024 adjusted EPS of $1.06, beating the analyst estimate of $1.02. Sales were $1.011 billion, surpassing the $1.000 billion estimate and showing a 2.74% increase YoY.
Hologic's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term. The company's performance indicates strong financial health and growth, which should boost investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100